14-day Premium Trial Subscription Sign Up For FreeGet Free

High volatility in Zomedica Pharmaceuticals Corp stock price on Thursday which ended trading at $0.69

StockInvest.us, 3 weeks ago


The Zomedica Pharmaceuticals Corp stock price gained 18.96% on the last trading day (Thursday, 26th Aug 2021), rising from $0.58 to $0.69. , and has now gained 6 days in a row. It is not often that stocks manage to gain so many days in a row, and falls for a day or two should be expected. During the day the stock fluctuated 21.80% from a day low at $0.66 to a day high of $0.80. The price has risen in 6 of the last 10 days and is up by 32.81% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 71 million more shares were traded than the day before. In total, 192 million shares were bought and sold for approximately $132.65 million.

HC Wainwright is very positive about ZOM and gave it a "Buy" rating on November 16, 2020. The price target was changed from $0.50 to $0.30.

Given the current short-term trend, the stock is expected to fall -41.71% during the next 3 months and, with a 90% probability hold a price between $0.24 and $0.40 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Zomedica Pharmaceuticals Corp

The Zomedica Pharmaceuticals Corp stock holds buy signals from both short and long-term moving averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $0.53 and $0.59. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Thursday, August 19, 2021, and so far it has risen 51.44%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 months Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.

On the downside, the stock finds support just below today's level from accumulated volume at $0.63 and $0.58.There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Zomedica Pharmaceuticals Corp finds support just below today's level at $0.63. If this is broken, then the next support from accumulated volume will be at $0.58 and $0.52.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.14 between high and low, or 21.80%. For the last week, the stock has had a daily average volatility of 14.06%.

Since the Zomedica Pharmaceuticals Corp has been rising for 6 days in a row, the risk over the next couple of days has increased. As we cannot be certain with regards to the size of the reaction, we urge caution.

Zomedica Pharmaceuticals Corp holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold/Accumulate candidate.

Check full Zomedica Pharmaceuticals Corp forecast and analysis here.